Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.
Hlatky
Lynn
L
Dana-Farber Cancer Institute and the Department of Radiation Oncology, Harvard Medical School, Boston, MA 02115, USA. Lynn_Hlatky@dfci.harvard.edu
Hahnfeldt
Philip
P
Folkman
Judah
J
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008833:Microcirculation / Q000187:drug effects / Q000473:pathology*; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*
D020533:Angiogenesis Inhibitors